| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/26/2007 | CN101091766A Medicine for treating ulcer in alimentary canal |
| 12/26/2007 | CN101091763A Method for controlling quality of tonic tablet for essence and blood |
| 12/26/2007 | CN101091762A Medicine for treating hepatic fibrosis |
| 12/26/2007 | CN101091759A Composition of medicine for treating gastric ulcer |
| 12/26/2007 | CN101091754A Medicine for treating chronic colitis and ulcerative colitis, and preparation method |
| 12/26/2007 | CN101091740A Medicine for treating constipation, and preparation method |
| 12/26/2007 | CN101091739A Application of total flavone from sticktight in preparing medicine for treating hepatic fibrosis in type of blood fluke |
| 12/26/2007 | CN101091727A Method for preparing capsules of wall broken spore powder of ganoderma lucidum |
| 12/26/2007 | CN101091722A Injection of hydrolyzed peptide of liver |
| 12/26/2007 | CN101091719A Compound medicinal preparation of proton pump inhibitor and aluminum magnesium carbonate, and preparation method |
| 12/26/2007 | CN101091707A Medicinal usage of kuhseng extractive |
| 12/26/2007 | CN101091585A Quinquefoliate fresh health care tobacco of |
| 12/26/2007 | CN101091519A Bean curd and manufacturing method thereof |
| 12/26/2007 | CN100357423C Warming and health care wine |
| 12/26/2007 | CN100357306C Rosemary acid anhydride compound ,its preparation method and use for treatment and prevention of AIDS |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100356976C Formula group for treating stomach and intestine neurosis and gastritis |
| 12/26/2007 | CN100356973C Medicine for treating indigestion and process for preparing the same |
| 12/26/2007 | CN100356962C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 12/26/2007 | CN100356961C Synergistic medicinal composition for treating hepatitis |
| 12/26/2007 | CN100356959C Traditional Chinese medicinal composition for reinforcing body fluid, tonifying spleen, dredging deposit and lowering qi, and prepn. method and application thereof |
| 12/26/2007 | CN100356956C Chinese medicine for treating ulcerative stomatitis |
| 12/26/2007 | CN100356953C Fat-reducing liver-protecting medicine and preparing method |
| 12/26/2007 | CN100356946C Cappillary artemisia-cape jasmine-rhubarb soft capsule and its prepn process |
| 12/26/2007 | CN100356933C Blood fat reducing and liver protecting medicine prepared with cassia seed extract |
| 12/26/2007 | CN100356929C Medicinal composition for auxiliary treatment of asthenia healthy qi and its quality control method |
| 12/26/2007 | CN100356922C Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 12/26/2007 | CN100356918C Enteric-coated quick releasing formulation of tannic acid and total matrine for treating enteritis |
| 12/26/2007 | CN100356915C Nanometer preparation of silybin and preparation method thereof |
| 12/26/2007 | CN100356913C R-bambuterol, its preparation and therapeutic uses |
| 12/26/2007 | CN100356912C Tiopronin freeze-dried prepn. and its preparing method |
| 12/26/2007 | CN100356871C Powder of amino acids and method for producing the same |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312238 Nonsedating α-2 agonists |
| 12/25/2007 | US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 12/25/2007 | US7312193 Calcium phosphopeptide complexes |
| 12/25/2007 | US7311932 sports drinks containing micronutrients, proteins and viable lactobacillus having positive effect on human intestinal mucous membranes |
| 12/25/2007 | US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response |
| 12/25/2007 | US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy |
| 12/21/2007 | WO2007146983A2 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
| 12/21/2007 | WO2007146173A2 A method for depletion of caries-causing bacteria in the oral cavity |
| 12/21/2007 | WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 12/21/2007 | WO2007145253A1 NF-ϰB ACTIVATION INHIBITOR |
| 12/21/2007 | WO2007144400A1 Benzylpiperazine derivatives as motilin receptor antagonists |
| 12/21/2007 | WO2007144345A2 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders |
| 12/21/2007 | WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses |
| 12/21/2007 | WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use |
| 12/21/2007 | WO2007143851A1 Fermented plant extracts, methods of production and uses |
| 12/21/2007 | WO2007124588A3 Colicinogenic strains of e. coli and use thereof for treatment of k88+-associated diarrhea |
| 12/21/2007 | WO2007113333A3 Antimicrobial preparations |
| 12/21/2007 | WO2007079000A3 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy |
| 12/21/2007 | WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators. |
| 12/21/2007 | WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/21/2007 | CA2682755A1 Fermented plant extracts, methods of production and uses |
| 12/21/2007 | CA2660648A1 Compositions and methods for treating diseases |
| 12/21/2007 | CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 12/21/2007 | CA2655081A1 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders |
| 12/21/2007 | CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor |
| 12/20/2007 | US20070293572 Anti-Fatigue Composition |
| 12/20/2007 | US20070293570 Pharmaceutical uses for alpha2delta ligands |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293543 THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z |
| 12/20/2007 | US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 12/20/2007 | US20070293532 Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade |
| 12/20/2007 | US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293522 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293511 Crf Receptor Antagonists and Methods |
| 12/20/2007 | US20070293509 treating eating disorders, obesity, type II diabetes, and substance abuse and/or addiction (including alcohol dependency and nicotine dependency); 6-(4-chloro-phenyl)-5-[methyl-(3-methyl-butyl)-amino]-pyrazine-2-carboxylic acid ((R)-2-cyclopropyl-2-hydroxy-propyl)-amide |
| 12/20/2007 | US20070293473 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| 12/20/2007 | US20070293464 Substituted Pyrimidine Compositions and Methods of Use |
| 12/20/2007 | US20070293431 Method for improving neurotransmission failure using a novel agent |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/20/2007 | US20070292517 Delivery Systems for Antacids |
| 12/20/2007 | US20070292507 Supportive Treatment of Liver Disease |
| 12/20/2007 | US20070292498 Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| 12/20/2007 | US20070292457 Electrical Nutritional Supplement |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/20/2007 | US20070292402 Lyophilised Lactic Acid Bacteria And Bifidobacteria Products With A High Degree Of Dispersibility |
| 12/20/2007 | US20070292371 Composition for promoting and maintaining oral health |
| 12/20/2007 | US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
| 12/19/2007 | EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use |